Within 24 h of administering 500 mL of AI, cumulative urinary excretion of AS-IV reached 3.91%, indicating linear pharmacokinetics within a 200500 mL dose range, with no accumulation observed following once-daily administration of AI (Xu et al., 2013)
ME/CFS, FM, and GWS were selected for this review due to (i) the common overlap of ME/CFS and FM where similar biological dysfunction might be expected and (ii) GWS, with its identifiable and specific trigger, likely to offer a different biological perspective
Most practitioners look for a consistent downward trend in antibodies and inflammation over 6-12 months
Keep up your great work, Peter Attia, bringing scientific facts to the individuals' decision table
AGE is an extract from garlic powder in a non-toxic solvent